FDA.reportPublic FDA data

NDC 0409-1390-21 - Meropenem

This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.

Product NDC
0409-1390
Requested NDC
0409-1390-21
Package NDCs from labels
0409-1390-21, 0409-1390-51
Manufacturer
Hospira, Inc.
Effective date
2024-11-06
Current FDA listing
Not matched in FDA.report NDC product tables

DailyMed Labels#

Label, Manufacturer, Effective date table
LabelManufacturerEffective dateType
Meropenem - Hospira, Inc.Hospira, Inc.2024-11-06HUMAN PRESCRIPTION DRUG LABEL

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
0409-1390-21Meropenem10 mL in 1 VIALINJECTION, POWDER, FOR SOLUTION107
0409-1390-51Meropenem10 in 1 CARTONINJECTION, POWDER, FOR SOLUTION107

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
0409-1390MEROPENEM INJECTION, POWDER, FOR SOLUTION [HOSPIRA, INC.]7Current NDC, Legacy NDC, 2 package rows20241108_092ebd9b-77a0-4877-afc3-dd8211730f71.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
0409-1390-21EA - Each0409-139064b4ed67-26f6-4608-97a9-6d1b28415fd012019-11-12
0409-1390-51EA - Each0409-139020c6caa6-39b7-48a7-8103-f3fd044a037012019-11-12

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 23 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
MeropenemMEROPENEMHikma Pharmaceuticals USA Inc.8a2a545e-b336-416a-be73-9e0a7ccf61772026-08-26Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMSagent Pharmaceuticalse8848f4a-bca9-4978-b0a1-38483fd4d6392026-03-31Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
VABOMEREMEROPENEM-VABORBACTAMMelinta Therapeutics, LLCe237fd0f-3050-42a3-b43e-b6fb4824e93d2026-02-27Warnings, Adverse reactionsExact identifier
unii: FV9J3JU8B1
MeropenemMEROPENEMBluePoint Laboratoriesca5f501c-6520-4d09-aae2-4f5db74d468f2025-12-12Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MEROPENEMMEROPENEMSavior Lifetec Corporation31dd2160-7dbd-51fa-e054-00144ff88e882025-11-24Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MEROPENEMMEROPENEMSandoz Inc0d37e43b-ff8d-495d-b9af-4fd5fce53d562025-11-14Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMQilu Antibiotics Pharmaceutical Co., Ltd.1f9591ed-3a6c-422e-b1be-7b3e4fe5bf3c2025-09-16Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMCivica, Inc.35466216-55ed-4836-8cbc-c8aafb079dae2025-09-12Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MEROPENEMMEROPENEMCivica, Incb0075b72-c3cc-f844-e053-2a95a90a417f2025-09-10Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
Meropenem and Sodium ChlorideMEROPENEM AND SODIUM CHLORIDEB. Braun Medical Inc.3b952a55-6ef7-45c8-be21-16eefe37ec2e2025-08-05Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMBROOKS STERISCIENCE LIMITED58e165b7-e230-4459-abf9-06d5ca1dd7b22025-07-31Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMEugia US LLCbf1d3433-9e3f-40a0-8bff-c8ceaa8bab7c2025-07-16Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMGland Pharma Limited4e4e2c0c-df54-4229-ab90-fa671ecedd572025-06-26Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMAmneal Pharmaceuticals LLCa456013b-b20e-4b29-b2f9-06f18f1ea6bd2025-06-09Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMHikma Pharmaceuticals USA Inc.d54fdbad-ca93-467c-92d7-c1bd88f3bbe32024-12-31Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMHospira, Inc.e9b6555f-20a1-4415-bb80-3d034cfab95b2024-11-06Warnings, Adverse reactionsExact identifier
application number: ANDA091404
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMHospira, Inc.092ebd9b-77a0-4877-afc3-dd8211730f712024-11-06Warnings, Adverse reactionsExact identifier
application number: ANDA091404
ndc (package): 0409-1390-51
ndc (package): 0409-1390-21
ndc (package): 0409-1391-21
ndc (package): 0409-1391-22
ndc (product): 0409-1390
ndc (product): 0409-1391
ndc11 (package): 00409139021
rxcui: 1722934
rxcui: 1722939
spl id: 6bd78500-6717-4df3-86d4-23cba124547e
spl set id: 092ebd9b-77a0-4877-afc3-dd8211730f71
unii: FV9J3JU8B1
MEROPENEMMEROPENEMXellia Pharmaceuticals USA LLC06d84c55-94ff-46e5-8477-b8881c12eb0a2024-07-10Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMARMAS PHARMACEUTICALS INCe1122310-c3ed-42f1-b189-301c221ff1f02022-07-29Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1
MeropenemMEROPENEMWG Critical Care, LLC6520ae3d-e149-499c-8152-36f6ab8616622021-06-30Warnings, Adverse reactionsExact identifier
rxcui: 1722934
rxcui: 1722939
unii: FV9J3JU8B1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.